Common heart pill under scrutiny for older patients as study weighs risks of stopping
A major clinical trial reveals that stopping statin drugs in older adults leads to higher rates of heart attacks, strokes, and death.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The STREAM trial, presented at the American Heart Association Scientific Sessions and published in the New England Journal of Medicine, evaluated whether stopping statin medications in older patients has a cost. According to Medscape, the Swiss-led trial involved more than 1800 older adults with a mean age of 77 who had at least two comorbidities and were taking statin drugs for primary prevention. A strategy of stopping statins was compared against continuing statins. Medical Daily reported that stopping statins met the STREAM trial's main test of non-inferiority, but more older adults experienced heart attacks, strokes, or died. The trial measured a primary outcome of myocardial infarction, stroke, or death from any cause, alongside quality of life measures, pain, falls, muscle function, and sarcopenia as counters. Medscape noted that the trialists reported restricted mean survival times (RMST), representing the area under the event-free survival curve up to 2 years. The RMST for the primary outcome was 98.5 weeks in the continuation arm versus 96.5 weeks in the discontinuation arm. The minus 2.0 week difference had 95% confidence intervals from minus 3.7 to minus 0.3 weeks. Medscape explained that patients who discontinued statins had significantly less event-free survival, with a primary outcome occurring in 12.7% of patients in the discontinuation arm compared to 9.2% in the continuation arm. Rates of myocardial infarction, stroke, and death from all causes were higher with stopping, and the data and safety monitoring board recommended that patients in the discontinuation arm be advised to restart their statin after reviewing the last interim analysis. Medscape criticized the New England Journal of Medicine conclusion that discontinuation was noninferior, arguing that the actual primary outcome event rate was way lower than the anticipated 34%, sitting instead at 10%. Fox News reported that the common heart pill is under scrutiny for older patients as the study weighs risks of stopping. Conversely, the American Heart Association website stated that discontinuing statins is generally safe for older adults without heart disease. Medscape detailed that secondary outcomes showed no differences in quality of life, pain, number of falls, or sarcopenia between the groups. The absolute risk increase for the full follow-up of 2 years was 3.5%, translating to a number needed to harm from stopping statins of 28. Medscape concluded that statin drugs provide patients like those in the trials a clinically meaningful reduction in the risk of myocardial infarction, stroke, and death.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 4d ago.
Quick answers
What was the average age of participants in the STREAM trial?
The mean age of the participants was 77 years old.
What percentage of patients in the discontinuation arm experienced a primary outcome?
A primary outcome occurred in 12.7% of patients in the discontinuation arm, compared to 9.2% in the continuation arm.
What did the data and safety monitoring board recommend during the trial?
The data and safety monitoring board recommended that patients in the discontinuation arm be advised to restart their statin after reviewing the report of the last interim analysis.
Coverage (13)
- STREAM, eZ-PAVE Add New Insights Into Statin Therapy Treatment American College of Cardiology · 4d ago
- Stopping statins after 70 may be safer than expected, but there's a catch Science Daily · 4d ago
- Stopping statins after 70 may be safer than expected, but there's a catch Science Daily · 4d ago
- Discontinuing statins generally safe for older adults without heart disease Medical Dialogues · 4d ago
- STREAM: Statin Discontinuation Noninferior in Older Adults Without CVD HCPLive · 4d ago
- Popular heart medication for older patients faces scrutiny as new study evaluates risks New York Post · 4d ago
- Study finds higher event rate after stopping statins in people aged 70+ UA.NEWS · 4d ago
- AHA: Discontinuing statins noninferior to continuation in older adults without known cardiovascular disease Medical Xpress · 4d ago
- Statins Work in Older Adults, Statistics Be Damned: The STREAM Trial Medscape · 4d ago
- Stopping statins met the STREAM trial's main test, but more older adults had heart attacks, strokes or died Medical Daily · 4d ago
- Discontinuing statins generally safe for older adults without heart disease www.heart.org · 4d ago
- STREAM, eZ-PAVE Add New Insights Into Statin Therapy Treatment American College of Cardiology · 4d ago
- Common heart pill under scrutiny for older patients as study weighs risks of stopping Fox News · 4d ago
Topics
Related trends
Does a heart stent prevent future heart attacks in stable patients? 25-year follow-up offers new insight
A 25-year follow-up of the landmark COURAGE trial shows upfront PCI heart stents offer no survival benefit for stable coronary disease.
Two-drug therapy reduces heart artery plaque more than statins alone
New clinical study findings reveal conflicting evidence regarding the efficacy of combining statins with ezetimibe.
Watchman device controversy: Did marketing outpace the science?
Atrial fibrillation increases stroke risk fivefold, prompting evolving strategies around oral anticoagulants and devices like the Watchman.
Why heart attacks can still happen even when bad cholesterol is low
New medical coverage explores why heart attacks can still occur in adults who maintain normal, low levels of bad cholesterol.
An unexpected bedroom tool could help stabilize blood sugar: study
A randomized trial found that using a HEPA air purifier in the bedroom at night reduced daily blood sugar swings by nearly 8% in adults with prediabetes.
Survival after sudden cardiac arrest didn’t improve despite training bystanders, emergency responders
A five-year North Carolina trial found that expanding CPR training, 911 dispatcher coaching, and early defibrillation across 31 counties did not improve survival after out-of-hospital cardiac arrest compared with 29 counties using usual care.